What Is Driving The Facial Injectable Giants To Spend More By 2030?

 Facial Injectable Industry Overview

The global facial injectable market size was valued at USD 16.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.1% from 2022 to 2030.

A growing focus on physical appearance among consumers has led to an increased demand for facial injectables in recent years. Increasing awareness regarding minimally invasive procedures due to various beauty campaigns being organized by key players in the market is also a driving factor for market growth. The ongoing COVID-19 pandemic has increased the time spent on video calls. Known as the ‘Zoom Boom’, several adults are becoming more aware of their appearance. This has increased demand for cosmetic surgeries, with Botox being one of the most popular products preferred.

Gather more insights about the market drivers, restrains and growth of the Global Facial Injectable Market

Patients are also opting for cosmetic surgeries owing to ease of recovery while staying at home. Thus, the market has witnessed a spike during the pandemic and this trend is expected to boost further. The presence of well-established key players like Allergan, Sinclair Pharma, Galderma with a comprehensive injectable fillers portfolio treating a broad range of skin indications like wrinkles, pigmentation, plumping of lips, scars, restoring facial fullness as well as enhancing facial contours is expected to drive the demand for facial injectable procedures thereby boosting market revenue. Increasing social media exposure, rising effectiveness, and approvals for facial injectable as well as the escalating desire among the population to look aesthetically appealing and young is expected to drive the market during the forecast period.

Minimally invasive surgeries are rapidly replacing invasive surgeries. For instance, according to the American Society of Plastic Surgeons (ASPS), in the U.S, nearly 18 million minimally invasive and surgical cosmetic products were performed in 2020, out of which nearly 16 million products were minimally invasive. Thus, the increasing adoption of minimally invasive surgeries, coupled with the availability of a wide range of such treatment options, is driving the market growth. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the U.S. was ranked 1st in terms of non-surgical products performed at a global level. Of these, injectables such as botulinum toxin and hyaluronic acid were among the most popular products performed. The country is backed by advanced treatment options and has the highest number of surgeons at a global level, with over 7,000 plastic surgeons as of 2019. These factors support market growth.

In June 2020, Allergan Aesthetics, a subsidiary of AbbVie Inc. (U.S.), received FDA approval for JUVÉDERM VOLUMA XC for the augmentation of the chin region in adults over the age of 21. Apart from this, in 2019, FDA approved, Jeuveau, which is similar to Botox, however, available at a lower cost compared to Botox. The product is found to be effective in reducing wrinkles. Signs of aging, include wrinkles and sagging of the skin due to low facial elasticity, dark spots, etc., and start appearing between 25 and 30 years of age and become more prominent from 30 to 65 years of age. Thus, the presence of a large population susceptible to various signs of aging is boosting the demand for facial injectable medicine globally.

The aesthetic industry witnessed a significant setback due to the COVID-19 pandemic in the initial quarters of 2020. However, many dermatologists reported that COVID-19 may act as a springboard that will drastically increase patient footfall post-pandemic. The survey conducted by Cynosure in June 2020 reported that the majority of the surveyed population showed a high willingness to opt for in-office non-invasive treatments. Even during the pandemic Botox and soft tissue fillers remained the most popular minimally invasive procedures in the U.S. This indicates that even though the facial injectable market faced a slight decline in the first half of 2020, it is going to recover strongly during the forecast period.


Browse through Grand View Research's Medical Devices Industry Research Reports.

  • Endoscopy Procedures Estimates Market - The global endoscopy procedures estimates market was valued at 222.9 million procedures in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 1.3% from 2022 to 2030.

 

  • Hyaluronic Acid Market - The global hyaluronic acid market size was valued at USD 8.5 billion in 2020 and is projected to witness a compound annual growth rate (CAGR) of 7.19% from 2021 to 2028.

 

Facial Injectable Market Segmentation

Grand View Research has segmented the global facial injectable market on the basis of product, application, and region:

  • Facial Injectable Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Collagen
    • Hyaluronic Acid (HA)
    • Botulinum Toxin Type A
    • Calcium Hydroxylapatite (CaHA)
    • Polymer Fillers
      • Polymethylmethacrylate beads (PMMA Microspheres)
      • Poly-L-Lactic Acid (PLLA)

 

  • Facial Injectable Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Aesthetics
    • Therapeutics

 

  • Facial Injectable Regional Outlook (Revenue, USD Million, 2017 - 2030)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • MEA

 

Market Share Insights

  • February 2020: Sinclair Pharma offered distribution partnership rights of Sculptra (poly-I-Iatic acid injectable) to Galderma SA specifically in Europe.
  • June 2020: Allergan Aesthetics, a subsidiary of AbbVie Inc. (U.S.), received FDA approval for JUVÉDERM VOLUMA XC for the augmentation of the chin region in adults over the age of 21. 

Key Companies profiled:

Some prominent players in the Facial Injectable market include

  • Ipsen
  • Merz Pharma
  • Suneva Medical, Inc.
  • Medytox Inc.
  • Sinclair Pharma
  • Bloomage BioTechnology Corporation Limited
  • Anika Therapeutics Inc.
  • Prollenium Medical Technologies
  • Galderma
  • Allergan, Inc.

 

Order a free sample PDF of the Facial Injectable Market Intelligence Study, published by Grand View Research. 

Comments

Post a Comment

Popular posts from this blog

Global Composable Infrastructure Market Analysis Based On Component, End-Use, And Region

  Composable Infrastructure Industry Overview The global composable infrastructure market size was valued at USD 2,678.6 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 50.4% from 2022 to 2030. The increasing demand for efficient application performance and business analytics workload is expected to contribute to the growth of this market. Due to the outbreak of the COVID-19 pandemic, organizations have struggled to keep up with their regular infrastructure needs. Enterprises of all sizes have expanded rapidly, thus driving the demand for robust IT infrastructure. Countries have experienced intensified data demand during the pandemic and underscored the importance of data centers. Furthermore, during this period, composable infrastructures helped firms in virtualizing their entire Information Technology (IT) infrastructure by allowing them to adapt to flexible and adaptive infrastructure. These benefits of composable infrastructure during the pand
Read more

Insights into the Future: Analyzing the Endoscopy Devices Industry from 2023 to 2030

  Endoscopy Devices csIndustry Data Book | Forecast 2030 Endoscopy Devices Industry Data Book - Endoscopes, Endoscopy Visualization System, Endoscopy Visualization Component And Operative Devices Market Size, Share, Trends Analysis And Segment Forecasts, 2023 – 2030 Grand View Research’s endoscopy devices industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with an endoscopy devices statistics e-book.   Access the Global Endoscopy Devices Industry Data Book, 2023 to 2030 , compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental
Read more

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p
Read more